We are live on
!
Find out more
LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$2.63B
1-Year Est. Return
31.52%
This Fund
S&P 500
This Quarter
Est. Return
+9.4%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$704M
AUM Growth
-$442M
(-39%)
Cap. Flow
-$488M
Cap. Flow
% of AUM
-69.26%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
402
New
6
Increased
57
Reduced
64
Closed
261
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ResMed
RMD
|
+$13.4M |
| 2 |
Toll Brothers
TOL
|
+$11.4M |
| 3 |
UnitedHealth
UNH
|
+$5.17M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$3.49M |
| 5 |
Surgery Partners
SGRY
|
+$2.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$21.1M |
| 2 |
Insulet
PODD
|
+$19M |
| 3 |
Lowe's Companies
LOW
|
+$16.2M |
| 4 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$15.8M |
| 5 |
Keysight
KEYS
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.95% |
| 2 | Consumer Discretionary | 18.04% |
| 3 | Technology | 14.64% |
| 4 | Financials | 13.2% |
| 5 | Industrials | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Albemarle
ALB
$15.1B
| – | – |
-6,442
| Closed | -$1.42M |
|
152
Alkermes
ALKS
$8.44B
| – | – |
-104,140
| Closed | -$2.94M |
|
153
Allstate
ALL
$64.7B
| – | – |
-3,659
| Closed | -$405K |
|
154
Alnylam Pharmaceuticals
ALNY
$30B
| – | – |
-76,103
| Closed | -$15.2M |
|
155
Amgen
AMGN
$225B
| – | – |
-4,787
| Closed | -$1.16M |
|
156
American Tower
AMT
$79.4B
| – | – |
-1,819
| Closed | -$372K |
|
157
Arista Networks
ANET
$265B
| – | – |
-5,484
| Closed | -$230K |
|
158
Aon
AON
$74.7B
| – | – |
-2,336
| Closed | -$737K |
|
|
APLS
159
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-71,180
| Closed | -$4.7M |
|
160
Aptiv
APTV
$10.1B
| – | – |
-3,451
| Closed | -$387K |
|
161
Algonquin Power & Utilities
AQN
$4.44B
| – | – |
-22,018
| Closed | -$337K |
|
162
argenx
ARGX
$54.8B
| – | – |
-19,026
| Closed | -$7.09M |
|
163
Array Technologies
ARRY
$799M
| – | – |
-48,844
| Closed | -$1.07M |
|
164
Arrowhead Research
ARWR
$12.3B
| – | – |
-98,342
| Closed | -$2.5M |
|
165
AvalonBay Communities
AVB
$25.7B
| – | – |
-2,702
| Closed | -$454K |
|
166
Broadcom
AVGO
$1.98T
| – | – |
-25,480
| Closed | -$1.63M |
|
167
Avery Dennison
AVY
$13.7B
| – | – |
-1,475
| Closed | -$264K |
|
168
AutoZone
AZO
$49.7B
| – | – |
-158
| Closed | -$388K |
|
169
Booz Allen Hamilton
BAH
$9.43B
| – | – |
-7,834
| Closed | -$726K |
|
170
BioCryst Pharmaceuticals
BCRX
$2.71B
| – | – |
-317,901
| Closed | -$2.65M |
|
171
Becton Dickinson
BDX
$50B
| – | – |
-1,636
| Closed | -$405K |
|
172
Brown-Forman Class B
BF.B
$12.8B
| – | – |
-4,046
| Closed | -$260K |
|
173
Biogen
BIIB
$30.9B
| – | – |
-2,686
| Closed | -$747K |
|
174
Booking.com
BKNG
$159B
| – | – |
-14,050
| Closed | -$1.49M |
|
175
Blackrock
BLK
$180B
| – | – |
-1,223
| Closed | -$818K |
|
Similar funds
SI
WWM
ACM
CCM
MG
PCMI
PCIG
MAMU
Lombard Odier Asset Management (Switzerland)'s Q2 2023 Portfolio in Review
As of Q2 2023, Lombard Odier Asset Management (Switzerland) held 402 positions worth $704M, down 39% from $1.15B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Lombard Odier Asset Management (Switzerland) withdrew a net $488M in Q2 2023, closing 261 positions and reducing 64 holdings. Its most notable exit was Insulet, an estimated $19M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 44% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Lombard Odier Asset Management (Switzerland) opened a new position in ResMed worth $13.2M.
- Lombard Odier Asset Management (Switzerland)'s largest Q2 2023 buy was ResMed: 60,254 shares worth $13.2M.
- Lombard Odier Asset Management (Switzerland) added most to UnitedHealth in Q2 2023, an estimated $5.17M increase.
- Lombard Odier Asset Management (Switzerland)'s biggest Q2 2023 reduction was DexCom, cutting an estimated $21.1M.
- Lombard Odier Asset Management (Switzerland) fully exited Insulet in Q2 2023, selling an estimated $19M.
- Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 32% of its $704M portfolio in Q2 2023.
- Lombard Odier Asset Management (Switzerland) opened 6 new positions and closed 261 in Q2 2023.
- Lombard Odier Asset Management (Switzerland)'s portfolio value fell 39% quarter-over-quarter to $704M.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.